IFP Advisors’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$166K Buy
810
+65
+9% +$12.9K ﹤0.01% 1651
2026
Q2
$140K Buy
745
+635
+577% +$92.8K ﹤0.01% 1750
2026
Q1
$10.7K Buy
110
+95
+633% +$9.6K ﹤0.01% 3112
2025
Q4
$1.2K Sell
15
-14
-48% -$918 ﹤0.01% 4014
2025
Q3
$1.35K Sell
29
-369
-93% -$14.4K ﹤0.01% 3831
2025
Q2
$15.4K Buy
398
+201
+102% +$7.72K ﹤0.01% 2685
2025
Q1
$7.18K Sell
197
-579
-75% -$23.5K ﹤0.01% 2689
2024
Q4
$34.2K Buy
+776
New +$39.2K ﹤0.01% 2018

Other funds holding RVMD

IFP Advisors's RVMD Position: Q3 2026 in Review

IFP Advisors increased its Revolution Medicines (RVMD) stake by 8.7% in Q3 2026, buying an estimated $12.9K and bringing the position to 810 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

IFP Advisors first reported a position in RVMD in Q4 2024 and has held it in 8 quarters since. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • IFP Advisors held 810 shares of Revolution Medicines worth $166K as of Q3 2026.
  • IFP Advisors bought 65 Revolution Medicines shares in Q3 2026, an estimated $12.9K.
  • Revolution Medicines made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #1651 holding.
  • IFP Advisors first reported a position in Revolution Medicines in Q4 2024 and has held it in 8 quarters since.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.